One-visit HPV screen-and-treat for cervical cancer in Khayelitsha
Research Project 1
['FUNDING_OTHER'] · COLUMBIA UNIVERSITY HEALTH SCIENCES · NIH-11146516
This project offers one-visit HPV testing and same-day treatment to women in a low-income Cape Town community to help prevent cervical cancer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLUMBIA UNIVERSITY HEALTH SCIENCES (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11146516 on ClinicalTrials.gov |
What this research studies
If you are a woman living in Khayelitsha, this project would offer HPV testing and, when needed, immediate treatment all in a single clinic visit so you don't need multiple trips. The team will work with local patients, clinic staff, and community leaders to design acceptable and practical ways to make the one-visit approach fit into routine primary care. The project uses point-of-care HPV tests and clinical evaluation followed by same-day treatment when indicated. The goal is to create strategies that can be scaled to other low-resource settings with high HIV burden.
Who could benefit from this research
Good fit: Women in Khayelitsha or similar low-income communities who are due for cervical cancer screening, especially those living with HIV, would be the ideal candidates.
Not a fit: People without a cervix, men, and those already treated for cervical cancer are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this could let women get screened and treated in one visit, reducing delays and preventing more cervical cancers.
How similar studies have performed: WHO recommends HPV-based screen-and-treat and prior studies have shown promise for single-visit HPV testing and same-day treatment, though routine clinic integration remains a challenge.
Where this research is happening
NEW YORK, UNITED STATES
- COLUMBIA UNIVERSITY HEALTH SCIENCES — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SAIDU, RAKIYA SAIDU — COLUMBIA UNIVERSITY HEALTH SCIENCES
- Study coordinator: SAIDU, RAKIYA SAIDU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Cancer Cause, Cancer Control, Cancer Control Science